NCT07149714View on ClinicalTrials.gov

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

February 17, 2028

Study Completion Date

February 17, 2029

Conditions
Ischemic Cardiovascular DiseaseMultivessel Coronary Artery DiseaseCoronary Artery DiseaseCardiogenic ShockAcute Heart Failure (AHF)Chronic Heart FailurePercutaneous Coronary Intervention
Interventions
DEVICE

iVAC 2L

The goal of this study is to investigate the safety and clinical efficacy of temporary mechanical support system with the iVAC 2L transaortic device in high-risk percutaneous coronary intervention (PCI) in Russia and Belarus. The POTOK trial will include patients with indications for elective, urgent and emergency PCI.

Trial Locations (1)

Unknown

RECRUITING

NMRCCardiologyRu, Moscow

All Listed Sponsors
lead

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV